Dentsply Sirona Inc

Healthcare · Medical Instruments & Supplies

8.70$ -0.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Dentsply Sirona Inc (XRAY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 898 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement XRAY
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	954	997	901	993	1,009	1,091	956	1,042	928	1,060	946	1,009	962	1,112	874	491	883	1,082	1,026	1,062	1,040	1,088	965	1,023	947	983	978	1,028	947	1,012	953	984	951	905	879	936	904	961	880	898	3,643
Cost of Revenue	441	455	409	449	450	498	442	489	452	535	447	469	448	501	406	315	451	512	447	467	471	495	450	442	439	466	459	478	452	490	447	473	456	459	413	446	463	518	453	405	1,839
Gross Profit	514	542	492	544	559	593	514	553	476	525	500	541	514	611	468	176	432	571	579	595	569	593	515	581	508	517	519	550	495	-474	506	511	495	446	466	490	441	443	427	493	1,804
Research & Development	0.0	129	0.0	0.0	0.0	152	161	161	161	161	131	131	131	131	34	18	29	44	40	43	39	59	45	45	41	43	46	49	46	43	42	41	40	42	36	37	37	40	44	45	166
Selling, General & Administrative	379	400	405	418	431	422	435	432	419	433	432	431	399	461	394	279	342	421	421	398	394	374	374	410	395	402	418	418	373	416	417	401	391	395	360	343	358	378	353	365	1,454
Total Operating Expenses	379	400	405	418	431	422	435	432	419	433	432	431	399	474	593	280	360	435	429	441	437	439	419	897	1,726	445	462	470	731	451	464	461	957	955	403	618	395	175	397	411	1,378
Operating Income	127	134	84	-1,048	108	-729	69	-1,154	46	82	47	68	110	137	-125	-104	72	135	150	154	132	154	93	126	-1,218	-45	54	80	-236	16	42	50	-462	-509	63	-128	46	268	30	82	426
Interest Expense	8.4	9.0	9.3	9.6	9.8	9.6	8.6	9.6	9.7	9.4	8.4	8.0	6.6	6.4	8.4	14	14	14	14	16	14	12	12	15	14	19	19	22	19	20	18	17	18	16	19	21	23	22	24	22	91
Pre-Tax Income	117	133	77	-1,065	98	-736	95	-1,162	32	77	54	48	107	138	-130	-120	57	123	145	131	113	138	83	91	-1,241	8.0	-28	46	-250	-15	31	34	-478	-523	44	-153	-230	-147	-42	72	-347
Income Tax Expense	25	25	17	-15	7.1	-63	14	-41	4.2	76	15	11	22	35	10	-24	9.0	24	33	35	29	36	18	18	-164	23	-5.0	-39	16	-15	14	38	17	-95	25	-109	198	-2.0	-32	36	200
Net Income	93	107	60	-1,050	91	-673	81	-1,122	28	1.8	39	36	85	102	-140	-95	47	99	112	96	84	102	65	73	-1,077	-15	-23	86	-266	67	18	-4.0	-494	-430	20	-45	-427	-146	-10	37	-546
EBITDA	211	247	162	-978	206	-645	162	-1,066	142	172	145	138	192	222	-44	-29	159	225	247	234	212	235	179	189	-1,145	34	138	154	-143	16	135	137	-371	-419	150	-41	-115	-32	61	258	172

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings